COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials

A listing of COPD (Chronic Obstructive Pulmonary Disease) medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Athens Alabama 35611

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Birmingham Alabama 35215

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Birmingham Alabama 35294

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Birmingham Alabama 35216

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Florence Alabama 35630

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

View More ▼

UPDATED

Mobile Alabama 36608

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Sheffield Alabama 35660

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

*see Various Departments* Alabama

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Andalusia Alabama

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

Andalusia Alabama

A clinical research study of GFF MDI (PT003), FF MDI (PT005), GP MDI (PT001) and Placebo MDI for the treatment of COPD, Severe

Andalusia Alabama 36420

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Andalusia Alabama

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Andalusia Alabama

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Andalusia Alabama

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Anniston Alabama 36207-5710

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Athens Alabama

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

Birmingham Alabama

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

Birmingham Alabama

A clinical research study of GFF MDI (PT003), FF MDI (PT005), GP MDI (PT001) and Placebo MDI for the treatment of COPD, Severe

Birmingham Alabama 35233

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Birmingham Alabama

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Birmingham Alabama 35294

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Birmingham Alabama

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Birmingham Alabama

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Birmingham Alabama

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Birmingham Alabama

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Birmingham Alabama

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive or Pulmonary Emphysema (COPD)

Florence Alabama

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Foley Alabama

A clinical research study of GFF MDI (PT003), FF MDI (PT005), GP MDI (PT001) and Placebo MDI for the treatment of COPD, Severe

Foley Alabama

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Gulf Shores Alabama

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Huntsville Alabama

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Jasper Alabama

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

Jasper Alabama

A clinical research study of GFF MDI (PT003), FF MDI (PT005), GP MDI (PT001) and Placebo MDI for the treatment of COPD, Severe

Jasper Alabama

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Jasper Alabama

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Jasper Alabama

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Jasper Alabama

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Mobile Alabama

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

Mobile Alabama

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Mobile Alabama

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Montgomery Alabama

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Tuscaloosa Alabama

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Arizona

Arizona Research Center
Phoenix Arizona 85023

A Long-Term, Randomized, Double-Blind Study of the Safety, Tolerability and Efficacy of Aclidinium Bromide At Two Dosage Levels When Administered to Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease

TR79
Phoenix Arizona 85381

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

TR76
Phoenix Arizona 85018

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Elite Clinical Studies, LLC
Phoenix Arizona 85018

Is COPD Leaving You Breathless? Right now we're enrolling adults with COPD ages 40 or older in a research study of an investigational medication for COPD.

View More ▼

UPDATED

Chandler Arizona 85284

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Flagstaff Arizona 86001

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Glendale Arizona 85306

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Glendale Arizona

Patients are needed to participate in a clinical research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)